Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)

ClinicalTrials.gov ID: NCT01322347

Public ClinicalTrials.gov record NCT01322347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Phase III Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) in Chronic Kidney Disease Patients Receiving Hemodialysis: The Continuous Replacement Using Iron Soluble Equivalents (CRUISE 2) Study

Study identification

NCT ID
NCT01322347
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Rockwell Medical Technologies, Inc.
Industry
Enrollment
294 participants

Conditions and interventions

Interventions

  • Soluble Ferric Pyrophosphate (SFP) Drug
  • Standard dialysate Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2011
Primary completion
Dec 31, 2013
Completion
Jan 31, 2014
Last update posted
Apr 25, 2017

2011 – 2014

United States locations

U.S. sites
38
U.S. states
15
U.S. cities
34
Facility City State ZIP Site status
Investigator Paragould Arkansas 72450
Investigator Pine Bluff Arkansas 71603
Investigator Alhambra California 91801
Investigator Beverly Hills California 90211
Investigator Glendale California 91204
Investigator La Mesa California 91942
Investigator Long Beach California 90807
Investigator Lynwood California 90262
Investigator Paramount California 90723
Investigator Whittier California 90603
Investigator Pembroke Pines Florida 33025
Investigator Augusta Georgia 30901
Investigator Macon Georgia 31217
Investigator Meridian Idaho 83642
Investigator Hines Illinois 60141
Investigator Rockville Maryland 20850
Investigator Detroit Michigan 48236
Investigator Pontiac Michigan 48341
Investigator Southfield Michigan 48034
Investigator Eatontown New Jersey 07724
Investigator Brooklyn New York 11212
Investigator Fresh Meadows New York 11365
Investigator Great Neck New York 11021
Investigator Orchard Park New York 14127
Investigator The Bronx New York 10461
Investigator Bethany Oklahoma 73008
Investigator Bethlehem Pennsylvania 18017
Investigator Philadelphia Pennsylvania 19106
Investigator Philadelphia Pennsylvania 19144
Investigator Nashville Tennessee 37205
Investigator Nashville Tennessee 37232
Investigator Arlington Texas 76015
Investigator Fort Worth Texas 76104
Investigator Fort Worth Texas 76105
Investigator Houston Texas 77004
Investigator Houston Texas 77099
Investigator San Antonio Texas 78229
Investigator Fairfax Virginia 22033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01322347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01322347 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →